Levorichter 30

Ethinylestradiol / Levonorgestrel, the active ingredients in Levorichter 30, are a combined oral contraceptive presented as a tablet for oral use. The formulation works by inhibiting ovulation, altering cervical mucus, and modifying the endometrial lining to prevent implantation, thereby providing reliable contraception for women of reproductive age.

GNH USA supplies Levorichter 30 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across markets with robust logistics and documentation support for cross‑border procurement.

Levorichter 30 is a combined hormonal contraceptive used within the family planning and reproductive health pathway. - Contraception: Prevents unintended pregnancy in women of reproductive age. - Menstrual cycle regulation: Helps achieve more regular menstrual bleeding patterns. - Acne improvement: May reduce androgen‑related acne in some women.

Levorichter 30 may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Breast tenderness: temporary swelling or discomfort. - Headache: occasional mild to moderate pain. - Spotting: irregular light bleeding between periods. - Mood changes: fluctuations in emotional state. - Weight gain: modest increase in body weight.

Serious or Rare Side Effects: - Deep vein thrombosis: blood clot formation in deep veins. - Pulmonary embolism: clot migration to lung vessels. - Stroke: interruption of cerebral blood flow. - Myocardial infarction: heart attack risk. - Severe allergic reaction: anaphylaxis or angioedema. - Liver tumor: rare hepatic neoplasm.

Before prescribing Levorichter 30, clinicians should consider several safety aspects. - Assess cardiovascular risk: evaluate history of thromboembolic events. - Avoid smoking: especially in women over 35 years of age. - Review liver function: contraindicated in severe hepatic disease. - Consider drug interactions: enzyme inducers may reduce efficacy. - Pregnancy category: X – contraindicated in pregnancy. - Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Levorichter 30 can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., rifampin, carbamazepine): may markedly reduce contraceptive effectiveness. - Hormone replacement therapy: combined use can increase thromboembolic risk. - Certain antiretrovirals (e.g., efavirenz): may lower plasma hormone levels.

Moderate Interactions (Monitor Closely): - Antifungal azoles (e.g., ketoconazole): may increase hormone concentrations. - SSRIs (e.g., fluoxetine): may elevate bleeding risk. - St. John’s wort: herbal supplement that can decrease contraceptive efficacy.